Your browser doesn't support javascript.
loading
SCOT: Tumor Sidedness and the Influence of Adjuvant Chemotherapy Duration on Disease Free Survival (DFS).
Saunders, Mark P; Iype, Rohan; Kelly, Caroline; Crosby, Jana; Kerr, Rachel; Harkin, Andrea; Allan, Karen; McQueen, John; Pearson, Sarah R; Cassidy, James; Medley, Louise C; Raouf, Sherif; Harrison, Mark; Brewster, Alison; Rees, Charlotte; Ellis, Richard; Thomas, Anne L; Churn, Mark; Iveson, Timothy; Maka, Noori.
Afiliación
  • Saunders MP; The Christie, Manchester, United Kingdom. Electronic address: mark.saunders8@nhs.net.
  • Iype R; The Christie, Manchester, United Kingdom.
  • Kelly C; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
  • Crosby J; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom.
  • Kerr R; University of Oxford, Oxford, United Kingdom.
  • Harkin A; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
  • Allan K; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
  • McQueen J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
  • Pearson SR; OCTO, University of Oxford, Oxford, United Kingdom.
  • Cassidy J; Cancer Research UK Glasgow Clinical Trials Unit, University of Glasgow, Glasgow, United Kingdom.
  • Medley LC; Royal United Hospital Bath, Bath, United Kingdom; South Devon Healthcare NHS Foundation Trust, Torquay, United Kingdom.
  • Raouf S; Barts Health NHS Trust, London, United Kingdom.
  • Harrison M; Mount Vernon Hospital, Northwood, United Kingdom.
  • Brewster A; Velindre Cancer Centre, Cardiff, United Kingdom.
  • Rees C; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom; Hampshire Hospitals NHS Foundation Trust, Basingstoke, United Kingdom.
  • Ellis R; Royal Cornwall Hospital, Truro, United Kingdom.
  • Thomas AL; University of Leicester, Leicester, United Kingdom.
  • Churn M; Worcester Royal Hospital, Worcester, United Kingdom.
  • Iveson T; University Hospital Southampton NHS Foundation Trust, Southampton, United Kingdom.
  • Maka N; Queen Elizabeth University Department of Pathology and Biorepository, Glasgow, United Kingdom.
Clin Colorectal Cancer ; 22(2): 231-237, 2023 06.
Article en En | MEDLINE | ID: mdl-36967267
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Colorrectales Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Clin Colorectal Cancer Asunto de la revista: GASTROENTEROLOGIA / NEOPLASIAS Año: 2023 Tipo del documento: Article